Suppr超能文献

COVID-19 患者在三级医院中的升高 D-二聚体水平:一项描述性横断面研究。

Raised D-dimer Level among COVID-19 Patients in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

机构信息

Department of Biochemistry, Nobel Medical College Teaching Hospital, Biratnagar-4, Nepal.

Department of Urology, Koshi Hospital, Biratnagar-9, Nepal.

出版信息

JNMA J Nepal Med Assoc. 2022 Mar 11;60(247):259-262. doi: 10.31729/jnma.7311.

Abstract

INTRODUCTION

Serum D-dimer is a protein fragment generated during the final phase of clot formation. Increased serum D-dimer levels indicate the hemostatic change in patients, likely related to the prothrombotic switch. As the world is battling with the damaging effect of coronavirus disease, it is very important to find out the early and effective predictors of prognosis to improve the management of COVID-19 patients. Thus, our study aims to find out the prevalence of increased D-dimer levels in coronavirus disease patients.

METHODS

A descriptive cross-sectional study was conducted on a total of 235 patients admitted in the COVID ward and COVID Intensive Care Units at a tertiary care hospital from July 2020 to August 2021 after getting ethical approval (Reference number: 401/2020) from the Institutional Review Committee. A convenience sampling method was used for sample collection. The highest recorded values for D-dimer during the hospital stay were taken for data collection. The data were entered in Microsoft Excel 2013 and analyzed using Statistical Package for the Social Sciences version 16.0. Point estimate at 95% Confidence Interval was calculated along with frequency, proportion, mean and standard deviation.

RESULTS

Among 235 patients, elevated D- dimer level was in 175 (74.46%) (68.88-80.04 at 95% Confidence Interval). Majority of the patients were males 136 (77.71%) whereas 39 (22.28%) of the patients were females.

CONCLUSIONS

The prevalence of raised D-dimer levels was quite higher in our studies compared to other studies done in different parts of the world. Thus, serum D-dimer level may serve as an early marker in improving the management of patients with coronavirus disease.

KEYWORDS

corona virus disease; d-dimer; disease severity.

摘要

简介

血清 D-二聚体是在血栓形成的最后阶段产生的蛋白质片段。血清 D-二聚体水平升高表明患者的止血发生变化,可能与血栓前状态转换有关。由于全世界都在与冠状病毒病的破坏性影响作斗争,因此找到早期有效的预后预测指标以改善 COVID-19 患者的管理非常重要。因此,我们的研究旨在发现冠状病毒病患者中 D-二聚体水平升高的患病率。

方法

本研究为描述性横断面研究,于 2020 年 7 月至 2021 年 8 月,在获得机构审查委员会伦理批准(参考编号:401/2020)后,在一家三级护理医院的 COVID 病房和 COVID 重症监护病房共对 235 名患者进行了研究。使用便利抽样法采集样本。采集住院期间 D-二聚体的最高记录值用于数据采集。将数据输入 Microsoft Excel 2013 并使用统计软件包 16.0 进行分析。计算 95%置信区间的点估计值以及频率、比例、均值和标准差。

结果

在 235 名患者中,有 175 名(74.46%)患者的 D-二聚体水平升高(95%置信区间为 68.88-80.04)。大多数患者为男性 136 例(77.71%),女性 39 例(22.28%)。

结论

与世界其他地区进行的不同研究相比,我们的研究中升高的 D-二聚体水平的患病率要高得多。因此,血清 D-二聚体水平可能作为改善冠状病毒病患者管理的早期标志物。

关键词

冠状病毒病;D-二聚体;疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d3b/9226744/e2182386099c/JNMA-60-247-259-g1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验